Neu Hc
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 16
-
- Antibiotic Use and Resistance 5
- Co-authors
- David E. FleischerJ. WinterCharles E. CherubinP LabthavikulR.C. SteinmanNalinee AswapokeeP AswapokeeDalia Cohen
- Journals
- The American Journal of Medicine (2 papers)PubMed Central (1 paper)PubMed (38 papers)
- Partner nations
- United States
In The Last Decade
Neu Hc
38 papers receiving 461 citations
Peers
Comparison fields: 5 of 82
- Molecular Medicine 215
- Applied Microbiology and Biotechnology 36
- Pharmacology 275
- Clinical Biochemistry 50
- Ophthalmology 54
Countries citing papers authored by Neu Hc
This map shows the geographic impact of Neu Hc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neu Hc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neu Hc more than expected).
Fields of papers citing papers by Neu Hc
This network shows the impact of papers produced by Neu Hc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neu Hc. The network helps show where Neu Hc may publish in the future.
Co-authorship network
The 9 scholars most cited alongside Neu Hc, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Microbiologic aspects of fluoroquinolones. | 1991 | 49 |
| 2 | In vitro activity of YTR-830H in combination with beta-lactamase unstable beta-lactams. | 1989 | 1 |
| 3 | Ciprofloxacin: an overview and prospective appraisal. | 1987 | 77 |
| 4 | Editors' roundtable: current formulas for P & T Committee success. (Part 2). | 1987 | 2 |
| 5 | The pharmacology of orally administered ciprofloxacin. | 1985 | 6 |
| 6 | Cefotaxime and desacetylcefotaxime: an example of advantageous antimicrobial metabolism. | 1984 | 51 |
| 7 | In vitro activity of pefloxacin compared to that of quinolones and other antimicrobial agents. | 1984 | 7 |
| 8 | Trends in the development of beta-lactam antibiotics. | 1984 | 3 |
| 9 | Urinary tract infections in the 1980s. | 1983 | 2 |
| 10 | Penicillins--new insights into their mechanisms of activity and clinical use. | 1982 | 10 |
| 11 | Hemorrhagic bullae associated with salmonella septicemia. | 1981 | 4 |
| 12 | In osteomyelitis the initial treatment is crucial. | 1980 | 1 |
| 13 | A symposium on the tetracyclines: a major appraisal. Introduction. | 1978 | 9 |
| 14 | Infections caused by gram-negative pathogens: new clinical considerations. | 1975 | 1 |
| 15 | Just how good is amoxicillin? | 1975 | 1 |
| 16 | Diagnosis and treatment of five opportunistic infections. | 1972 | 2 |
| 17 | Antibiotic resistance of salmonella in northeastern United States 1968-199. | 1971 | 9 |
| 18 | In vitro studies of a semisynthetic penicillin, 6-(D(-)- -carboxy-3-thienylacetamido) penicillanic acid (BRL 2288), active against Pseudomonas. | 1970 | 30 |
| 19 | Adult Hemophilus influenzae meningitis; associated with disseminated intravascular coagulation. | 1969 | 8 |
| 20 | Effect of human lysozyme on gram-positive and gram-negative bacteria. | 1968 | 11 |
About Neu Hc
Neu Hc is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Pharmacology, Clinical Biochemistry and Geriatrics and Gerontology, having authored 41 papers that have together received 520 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Antibiotic Resistance in Bacteria (16 papers), Antibiotic Use and Resistance (5 papers), Bacterial Identification and Susceptibility Testing (4 papers), Pharmaceutical studies and practices (3 papers), Infectious Diseases and Tuberculosis (3 papers), Ocular Infections and Treatments (2 papers) and Microbial Natural Products and Biosynthesis (2 papers). The work is most often cited by research in Molecular Medicine (215 citations), Applied Microbiology and Biotechnology (36 citations), Pharmacology (275 citations), Clinical Biochemistry (50 citations) and Ophthalmology (54 citations). Neu Hc has collaborated with scholars based in United States. Frequent co-authors include David E. Fleischer, J. Winter, Charles E. Cherubin, P Labthavikul, R.C. Steinman, Nalinee Aswapokee, P Aswapokee, Dalia Cohen and SE Hickman. Their work appears in journals such as The American Journal of Medicine, PubMed Central and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.